Cite

HARVARD Citation

    van Hasselt, J. et al. (n.d.). Disease Progression/Clinical Outcome Model for Castration‐Resistant Prostate Cancer in Patients Treated With Eribulin. CPT: pharmacometrics & systems pharmacology. pp. 386-395. [Online]. 
  
Back to record